Ritu Gaur
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Porphyrins as Novel Therapeutics for HIV: Mechanism, Advances, and Challenges.
Journal: AIDS research and human retroviruses
Published: April 21, 2026
C-28 linker length modulates the activity of second-generation HIV-1 maturation inhibitors.
Journal: Virology journal
Published: November 19, 2024
Fullerene (C60 & C70)-Meso-Tris-4-Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild-Type and Drug-Resistant HIV-1 Clades B and C.
Journal: Journal of medical virology
Published: September 11, 2024
MALAT1 is important for facilitating HIV-1 latency reversal in latently infected monocytes.
Journal: Gene
Published: August 28, 2024
Transcriptomic study reveals alteration in the expression of long non-coding RNAs (lncRNAs) during reversal of HIV-1 latency in monocytic cell line.
Journal: Molecular biology reports
Published: June 18, 2024
Author Correction: Porphyrins with combinations of 4-carboxyphenyl and 4-hydroxyphenyl substituents in meso-positions as anti-HIV-1 agents.
Journal: Scientific reports
Published: June 18, 2024
Construction of a HIV-1 subtype C 3D model using homology modeling and in-silico docking, molecular dynamics simulation, and MM-GBSA calculation of second-generation HIV-1 maturation inhibitor(s).
Journal: Journal of biomolecular structure & dynamics
Published: July 25, 2023
Construction and characterization of a full-length, replication-competent and infectious enhanced green fluorescence protein-tagged HIV-1 subtype C molecular clone.
Journal: Virology
Published: January 07, 2022
Two cationic meso-thiophenium porphyrins and their zinc-complexes as anti-HIV-1 and antibacterial agents under non-photodynamic therapy (PDT) conditions.
Journal: Bioorganic & medicinal chemistry letters
Published: December 14, 2021
Last Updated: 09/26/2026